A Clinical Study on Safety and Effectiveness of Mesenchymal Stem Cell Exosomes for the Treatment of COVID-19.
Clinical trial NCT05787288 · UNKNOWN
Trial details
- NCT number
- NCT05787288
- Sponsor
- First Affiliated Hospital of Wenzhou Medical University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-23
- Primary completion
- 2024-01-23
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.